These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6806235)

  • 41. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
    Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; McKevitt M; Montgomery AB
    J Antimicrob Chemother; 2011 Oct; 66(10):2398-404. PubMed ID: 21784781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
    Nakao M; Kondo M; Imada A
    J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics.
    Pletzer D; Braun Y; Dubiley S; Lafon C; Köhler T; Page MGP; Mourez M; Severinov K; Weingart H
    J Bacteriol; 2015 Jul; 197(13):2217-2228. PubMed ID: 25917903
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Karlowsky JA; Kazmierczak KM; de Jonge BLM; Hackel MA; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic diffusion pathways in the outer membrane of Pseudomonas aeruginosa.
    Kitahara T; Yoneyama H; Nakae T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):457-61. PubMed ID: 9299531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Stern M
    Antimicrob Agents Chemother; 1983 Apr; 23(4):548-50. PubMed ID: 6683094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Structural basis of the xenobiotic-antibiotics transporter function].
    Nakae T
    Seikagaku; 2007 Jun; 79(6):550-6. PubMed ID: 17663159
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SQ 26,180, a novel monobactam. II Isolation, structure determination and synthesis.
    Parker WL; Koster WH; Cimarusti CM; Floyd DM; Liu WC; Rathnum ML
    J Antibiot (Tokyo); 1982 Feb; 35(2):189-95. PubMed ID: 7076565
    [No Abstract]   [Full Text] [Related]  

  • 51. Inactivation of dihydrostreptomycin by Pseudomonas aeruginosa.
    Kobayashi F; Yamaguchi M; Mitsuhashi S
    Jpn J Microbiol; 1971 Jul; 15(4):381-2. PubMed ID: 4107311
    [No Abstract]   [Full Text] [Related]  

  • 52. Precedence for the Role of Indole with Pathogens.
    Wood TK; Lee J
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363035
    [No Abstract]   [Full Text] [Related]  

  • 53. Penetration of antibiotics into decubitus ulcers.
    Berger SA; Barza M; Haher J; Bell D; Waintraub S; Burtyk ML; Kane A
    J Antimicrob Chemother; 1981 Feb; 7(2):193-5. PubMed ID: 6783609
    [No Abstract]   [Full Text] [Related]  

  • 54. Antimicrobial susceptibility of Salmonella typhimurium carrying the outer membrane permeability mutation SS-B.
    Vaara M
    Antimicrob Agents Chemother; 1990 May; 34(5):853-7. PubMed ID: 2193622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth curve patterns of Escherichia coli and Pseudomonas aeruginosa submitted to different SQ 26,776 concentrations.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():89-96. PubMed ID: 6799486
    [No Abstract]   [Full Text] [Related]  

  • 56. In-vitro studies on SQ 26,776, a new monobactam antibiotic.
    Russell AD
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():81-8. PubMed ID: 6799485
    [No Abstract]   [Full Text] [Related]  

  • 57. In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Bremner DA
    J Antimicrob Chemother; 1985 Oct; 16(4):457-61. PubMed ID: 3934129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The problems in the outer membrane permeability and the antibiotic resistance of Pseudomonas aeruginosa.
    Nakae T
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):115-21. PubMed ID: 1667326
    [No Abstract]   [Full Text] [Related]  

  • 59. Penetration of SQ 26,776, a new monobactam antibiotic, into Escherichia coli and Pseudomonas aeruginosa.
    Russell AD; Furr JR
    J Antimicrob Chemother; 1982 Apr; 9(4):329-31. PubMed ID: 6806235
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.